Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

USA - NYSE:CLVT - JE00BJJN4441 - Common Stock

4.01 USD
-0.1 (-2.43%)
Last: 9/19/2025, 6:40:00 PM
4.01 USD
0 (0%)
After Hours: 9/19/2025, 6:40:00 PM
Fundamental Rating

3

Overall CLVT gets a fundamental rating of 3 out of 10. We evaluated CLVT against 82 industry peers in the Professional Services industry. CLVT may be in some trouble as it scores bad on both profitability and health. CLVT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CLVT had positive earnings in the past year.
In the past year CLVT had a positive cash flow from operations.
In the past 5 years CLVT always reported negative net income.
In the past 5 years CLVT always reported a positive cash flow from operatings.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

CLVT's Return On Assets of -3.79% is on the low side compared to the rest of the industry. CLVT is outperformed by 69.51% of its industry peers.
CLVT has a worse Return On Equity (-8.68%) than 69.51% of its industry peers.
With a Return On Invested Capital value of 1.67%, CLVT is not doing good in the industry: 64.63% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for CLVT is significantly below the industry average of 12.76%.
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROIC 1.67%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

CLVT's Operating Margin of 8.41% is fine compared to the rest of the industry. CLVT outperforms 68.29% of its industry peers.
CLVT's Operating Margin has improved in the last couple of years.
CLVT has a Gross Margin of 66.07%. This is in the better half of the industry: CLVT outperforms 79.27% of its industry peers.
In the last couple of years the Gross Margin of CLVT has remained more or less at the same level.
Industry RankSector Rank
OM 8.41%
PM (TTM) N/A
GM 66.07%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

0

2. Health

2.1 Basic Checks

CLVT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CLVT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLVT has more shares outstanding
Compared to 1 year ago, CLVT has a worse debt to assets ratio.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.40, we must say that CLVT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CLVT (-0.40) is worse than 81.71% of its industry peers.
CLVT has a debt to FCF ratio of 13.65. This is a negative value and a sign of low solvency as CLVT would need 13.65 years to pay back of all of its debts.
With a Debt to FCF ratio value of 13.65, CLVT is not doing good in the industry: 62.20% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.90 indicates that CLVT is somewhat dependend on debt financing.
The Debt to Equity ratio of CLVT (0.90) is worse than 65.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Altman-Z -0.4
ROIC/WACC0.23
WACC7.12%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.91 indicates that CLVT may have some problems paying its short term obligations.
CLVT has a Current ratio of 0.91. This is in the lower half of the industry: CLVT underperforms 76.83% of its industry peers.
A Quick Ratio of 0.91 indicates that CLVT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.91, CLVT is doing worse than 76.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CLVT have decreased by -7.69% in the last year.
CLVT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.87% yearly.
The Revenue has decreased by -3.92% in the past year.
CLVT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.28% yearly.
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%

3.2 Future

CLVT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.12% yearly.
Based on estimates for the next years, CLVT will show a small growth in Revenue. The Revenue will grow by 0.76% on average per year.
EPS Next Y-9.72%
EPS Next 2Y-2.21%
EPS Next 3Y2.37%
EPS Next 5Y0.12%
Revenue Next Year-6.64%
Revenue Next 2Y-3.48%
Revenue Next 3Y-1.61%
Revenue Next 5Y0.76%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.57, the valuation of CLVT can be described as very cheap.
CLVT's Price/Earnings ratio is rather cheap when compared to the industry. CLVT is cheaper than 96.34% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.38. CLVT is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 5.67, the valuation of CLVT can be described as very cheap.
95.12% of the companies in the same industry are more expensive than CLVT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, CLVT is valued rather cheaply.
Industry RankSector Rank
PE 5.57
Fwd PE 5.67
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLVT indicates a rather cheap valuation: CLVT is cheaper than 89.02% of the companies listed in the same industry.
91.46% of the companies in the same industry are more expensive than CLVT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.14
EV/EBITDA 7.27
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.21%
EPS Next 3Y2.37%

0

5. Dividend

5.1 Amount

CLVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (9/19/2025, 6:40:00 PM)

After market: 4.01 0 (0%)

4.01

-0.1 (-2.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners62.11%
Inst Owner ChangeN/A
Ins Owners0.84%
Ins Owner Change11.27%
Market Cap2.70B
Analysts74.67
Price Target5.2 (29.68%)
Short Float %10.92%
Short Ratio9.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.04%
Min EPS beat(2)1.75%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)5.47%
Min EPS beat(4)0.21%
Max EPS beat(4)18.32%
EPS beat(8)7
Avg EPS beat(8)6.13%
EPS beat(12)11
Avg EPS beat(12)8.6%
EPS beat(16)15
Avg EPS beat(16)8.34%
Revenue beat(2)2
Avg Revenue beat(2)2.7%
Min Revenue beat(2)2.04%
Max Revenue beat(2)3.36%
Revenue beat(4)2
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-4.81%
Max Revenue beat(4)3.36%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.28%
PT rev (1m)0%
PT rev (3m)-3.43%
EPS NQ rev (1m)-0.19%
EPS NQ rev (3m)-5.36%
EPS NY rev (1m)1.14%
EPS NY rev (3m)-0.09%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)0.95%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 5.57
Fwd PE 5.67
P/S 1.08
P/FCF 8.14
P/OCF 4.27
P/B 0.54
P/tB N/A
EV/EBITDA 7.27
EPS(TTM)0.72
EY17.96%
EPS(NY)0.71
Fwd EY17.65%
FCF(TTM)0.49
FCFY12.28%
OCF(TTM)0.94
OCFY23.44%
SpS3.72
BVpS7.43
TBVpS-7.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROCE 2.12%
ROIC 1.67%
ROICexc 1.74%
ROICexgc N/A
OM 8.41%
PM (TTM) N/A
GM 66.07%
FCFM 13.24%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
ROICexc(3y)1.93%
ROICexc(5y)1.38%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.36%
ROCE(5y)1.69%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Debt/EBITDA 4.76
Cap/Depr 40.65%
Cap/Sales 12.02%
Interest Coverage 250
Cash Conversion 66.51%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z -0.4
F-Score6
WACC7.12%
ROIC/WACC0.23
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y-9.72%
EPS Next 2Y-2.21%
EPS Next 3Y2.37%
EPS Next 5Y0.12%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%
Revenue Next Year-6.64%
Revenue Next 2Y-3.48%
Revenue Next 3Y-1.61%
Revenue Next 5Y0.76%
EBIT growth 1Y-19.21%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9479.49%
EBIT Next 3Y362.47%
EBIT Next 5Y154.38%
FCF growth 1Y-31.45%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-14.01%
OCF growth 3Y25.93%
OCF growth 5Y40.62%